LOS ANGELES CAPITAL MANAGEMENT LLC

Position in RCKT — Rocket Pharmaceuticals, Inc.

CIK 1177206 LOS ANGELES, CA

Position in RCKT

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$1,190,478

+$532,701 QoQ

Shares Held

348,093

+85.7% QoQ

Ownership

0.317%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#38

of 180 holders

Holding Since

Dec 2020

12 quarters on record

Voting authority Sole 12% Shared 0% None 88%

Healthcare · as of Jun 30, 2026

LOS ANGELES CAPITAL MANAGEMENT LLC holds $888,562,834 across 167 Biotechnology names. RCKT ranks #31 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	729,635	$219,642,024
2	HALO	Halozyme Therapeutics, Inc.	1,938,035	$151,689,999
3	CAI	Caris Life Sciences, Inc.	3,958,531	$70,541,022
4	INCY	Incyte Corp	578,986	$65,633,852
5	VRTX	Vertex Pharmaceuticals Inc / Ma	130,802	$64,973,277
6	EXEL	Exelixis, Inc.	1,159,457	$63,086,055
7	REGN	Regeneron Pharmaceuticals, Inc.	98,585	$61,471,690
8	RPRX	Royalty Pharma plc	877,674	$49,211,181

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,190,478	348,093	+85.7%	Shares	Sole	2026-08-13
2025-12-31	$657,777	187,401	-29.1%	Shares	Sole	2026-02-11
2025-09-30	$862,045	264,431	+253.0%	Shares	Sole	2025-10-20
2025-06-30	$183,546	74,917	+205.6%	Shares	Sole	2025-08-07
2024-06-30	$527,872	24,518	0.0%	Shares	Sole	2024-08-05
2024-03-31	$660,514	24,518	0.0%	Shares	Sole	2024-04-05
2023-12-31	$734,804	24,518	+75.4%	Shares	Sole	2024-02-06
2023-09-30	$286,450	13,980	+70.7%	Shares	Sole	2023-11-06
2021-09-30	$244,799	8,190	0.0%	Shares	Sole	2021-11-08
2021-06-30	$362,735	8,190	-5.8%	Shares	Sole	2021-08-05
2021-03-31	$385,575	8,690	-16.1%	Shares	Sole	2021-05-05
2020-12-31	$567,868	10,355	—	Shares	Sole	2021-03-10
No filing history on record for this holder in this stock.